Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Neurocase. 2012 Nov 5;20(1):10.1080/13554794.2012.732087. doi: 10.1080/13554794.2012.732087

Table 5.

Neuropsychological assessment of the Patient No. 2

Age: years, months (years since onset)
56/4 (5) 57/2 (6) 57/10 (6)

Global measures
MMSE (max.30 points) 22 14 4
BDRS (max. 28 points) 6 20 21
ACE-R (max.100 points) NA 33 11
ACE-R attention and orientation (max.18 points) NA 6 3
ACE-R memory (max.26 points) NA 5 0
ACE-R verbal fluency (max. 14 points) NA 0 0
ACE-R language function (max. 26 points ) NA 13 6
ACE-R visuospatial function (max.16 points) NA 9 2
DRS NA 62 NA

Attention and memory
Digit Span forward from WAIS-R- max. span 4 5 5
Digit Span backward from WAIS-R- max. span 2 2 0
AVLT-learning curve 3-4-7-8-8 1-3-4-4-5 NA
AVLT-delayed recall 5 0 NA
AVLT-retention (%) 63 0 NA
AVLT-sum of intrusions 5 2 NA
HVLT - learning curve NA 5-5-5 1-1-0
HVLT- delayed recall NA 2 0
HVLT-retention (%) NA 40 0
HVLT- delayed recognition NA 0 0

Semantic memory
Information from WAIS-R (raw score) 6 2 NA

Abstract thinking
Similarities from WAIS-R (raw score) 0 0 NA

Verbal fluency
semantic fluency trials (animals, plants-summed) NA 2 0
phonemic fluency trials ( K”, P”- summed) NA 2 0

ACE-R, Addenbrooke Cognitive Examination- Revised; AVLT, Auditory Verbal Learning Test; BDRS, Blessed Dementia Rating Scale; BDAE, Boston Diagnostic Aphasia Examination; BNT, Boston Naming Test; HVLT, Hopkins Verbal Learning Test; MMSE, Mini Mental State Examination; NA, not available